Browsing by Author "Labarca, JA"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Antiphospholipid syndrome associated with cytomegalovirus infection: Case report and review
    (1997) Labarca, JA; Rabaggliati, RM; Radrigan, FJ; Rojas, PP; Perez, CM; Ferres, MV; Acuna, GG; Bertin, PA
    Antiphospholipid antibodies are commonly related to connective tissue disorders, the use of certain drugs, and infection. It is thought that antiphospholipid syndrome (APS) is associated primarily with connective tissue disorders, We describe a healthy young male who had an episode of APS that was associated with cytomegalovirus infection and who developed mesenteric and femoropopliteal thrombosis, He responded well to treatment with anticoagulants; 6 months after the onset of APS, IgM and IgG anticardiolipin antibody titers declined. We point out the importance of screening for infectious agents in cases of APS; if the agents are identified, APS may be transitory.
  • Thumbnail Image
    Item
    Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients
    (LIPPINCOTT WILLIAMS & WILKINS, 2003) Riquelme, AJ; Calvo, MA; Guzman, AM; Depix, MS; Garcia, P; Perez, C; Arrese, M; Labarca, JA
    Saccharomyces boulardii is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii. Molecular typing confirmed clonality in isolate strains from patients and the S. boulardii capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use.